When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

In separate DLL3 antibody-drug conjugate (ADC) deals, Roche licensed from Innovent Biologics and Ideaya reached for Hengrui.

A new report from Renub Research forecasts that the diabetes device market in China will grow from US$6.22 billion in 2023 to US$12.74 billion by 2032, representing a compound annual growth rate (CAGR ...

Alibaba to sell stake in China's hypermarket chain Sun Art. Brand prescription drugs to rise an average 4.5% in 2025. Cybertruck blast driver identified; link to New Orleans attacker growing ...

China's economy demonstrated remarkable resilience and adaptability in 2024 amid complex domestic and global landscapes. The ...

This will be Sanofi's largest single investment in China since entering the country in 1982. Sanofi has not been alone ...

China's economy demonstrated remarkable resilience and adaptability in 2024, amid complex domestic and global landscapes. The ...

BEIJING, Dec. 31 (Xinhua) -- China's economy demonstrated remarkable resilience and adaptability in 2024, amid complex domestic and global landscapes. The country's economic trajectory was marked by ...

Cytokinetics is advancing aficamten, a potential competitor to Camzyos, targeting hypertrophic cardiomyopathy. Read my CYTK ...

RTW Biotech added that last Monday, Corxel said it acquired worldwide rights to an oral small molecule glucagon-like peptide-1 receptor agonist known as CX11 from Suzhou, China-based Vincentage Pharma ...

INR:1981. kerala lottery chart 2007 Sanofi launches international multicenter Phase 3 trial of BTK inhibitor in China R&D Daily丨Hanlin's "Adalimumab" ...

INR:2258. guru rummy download Pfizer hits a wall, Sanofi is dragged down, and Fosun is directly eliminated. The hospital drug market has undergone major chang ...